Pay in 4 interest-free payments of $6.12 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
The 2026 Part D out-of-pocket cap of $2,000 provides a ceiling but reaching it requires significant spending first
For thousands of people, these compounded medications were more affordable than brand-name versions
For people with type 2 diabetes, insulin and sulfonylureas carry an additional risk of hypoglycaemia if used alongside retatrutide, and dose adjustments should only be made under close clinical supervision
Ovidrel will drop from $251 to $84
US$ 26.55
US$ 28.62
US$ 22.07
US$ 24.29
US$ 24.90
US$ 28.12
